You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

HYDRODIURIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydrodiuril, and what generic alternatives are available?

Hydrodiuril is a drug marketed by Merck and is included in one NDA.

The generic ingredient in HYDRODIURIL is hydrochlorothiazide. There are thirty-two drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrodiuril

A generic version of HYDRODIURIL was approved as hydrochlorothiazide by PRINSTON INC on March 29th, 2002.

  Try a Trial

Drug patent expirations by year for HYDRODIURIL
Recent Clinical Trials for HYDRODIURIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
The First Affiliated Hospital of Zhengzhou UniversityPhase 4
Ruijin HospitalPhase 4
Zhongda HospitalPhase 4

See all HYDRODIURIL clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for HYDRODIURIL

US Patents and Regulatory Information for HYDRODIURIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck HYDRODIURIL hydrochlorothiazide TABLET;ORAL 011835-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck HYDRODIURIL hydrochlorothiazide TABLET;ORAL 011835-006 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Merck HYDRODIURIL hydrochlorothiazide TABLET;ORAL 011835-007 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.